Journal
HUMAN MUTATION
Volume 39, Issue 1, Pages 124-139Publisher
WILEY
DOI: 10.1002/humu.23354
Keywords
disorders of sex development; genotype-phenotype correlation; mutation; NR5A1; oligogenic; variable expressivity
Categories
Funding
- National Health and Medical Research Council, Australia [546517]
- Ian Potter Centre for Genomics and Personalised Medicine
- Victorian Government's Operational Infrastructure Support Program
- National Health and Medical Research Council Australia Independent Medical Research Institutes Infrastructure Support Scheme
Ask authors/readers for more resources
Variants in the NR5A1 gene encoding SF1have been described in a diverse spectrum of disorders of sex development (DSD). Recently, we reported the use of a targeted gene panel for DSD where we identified 15 individuals with a variant in NR5A1, nine of which are novel. Here, we examine the functional effect of these changes in relation to the patient phenotype. All novel variants tested had reduced trans-activational activity, while several had altered protein level, localization, or conformation. In addition, we found evidence of new roles for SF1 protein domains including a region within the ligand binding domain that appears to contribute to SF1 regulation of Mullerian development. There was little correlation between the severity of the phenotype and the nature of the NR5A1 variant.We report two familial cases ofNR5A1deficiency with evidence of variable expressivity; we also report on individuals with oligogenic inheritance. Finally, we found that the nature of the NR5A1 variant does not inform patient outcomes (including pubertal androgenization and malignancy risk). This study adds nine novel pathogenic NR5A1 variants to the pool of diagnostic variants. It highlights a greater need for understanding the complexity of SF1 function and the additional factors that contribute.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available